Bio-Rad Laboratories, Inc. (BIO) Stock Overview
Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Bio-Rad Laboratories, Inc. (BIO)
Key Financials
Key Financials
Market Cap
9.7B
P/E Ratio
43.13
EPS (TTM)
$9.28
ROE
0.03%
BIO Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Bio-Rad Laboratories, Inc. (NYSE: BIO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bio-Rad Laboratories, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BIO on the NYSE shows an RSI of 76.72, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $182.14 for the NYSE listing.
Key metrics behind Bio-Rad Laboratories, Inc.'s NYSE-traded stock include a P/E ratio of 43.13 and a market capitalization of 9.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BIO on the NYSE.